Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Health Care REITs Industry Analysis

UpdatedMay 21, 2026
DataAggregated Company Financials
Companies19
  • 7D-0.5%
  • 3M4.4%
  • 1Y37.3%
  • YTD15.1%

In the last week, Health Care REITs has been flat. The past year has been better, since the industry has gained 37% in that time. As for the next few years, earnings are expected to grow by 24% per annum.

Industry Valuation and Performance

Has the U.S. Health Care REITs Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 21 May 2026US$287.8bUS$34.7bUS$1.6b39.3x178.1x8.3x
Sat, 18 Apr 2026US$278.1bUS$33.1bUS$361.5m42.8x769.3x8.4x
Mon, 16 Mar 2026US$265.7bUS$32.5bUS$355.1m37.4x748x8.2x
Wed, 11 Feb 2026US$253.2bUS$31.8b-US$403,376,000.0036x-627.7x8x
Fri, 09 Jan 2026US$239.7bUS$31.5bUS$440.3m32.3x544.5x7.6x
Sun, 07 Dec 2025US$253.5bUS$31.5bUS$440.3m32.2x575.8x8.1x
Tue, 04 Nov 2025US$233.5bUS$31.7bUS$456.3m29.5x511.7x7.4x
Thu, 02 Oct 2025US$231.1bUS$30.4bUS$354.3m32.5x652.3x7.6x
Sat, 30 Aug 2025US$220.9bUS$30.4bUS$332.7m34.8x664x7.3x
Mon, 28 Jul 2025US$209.0bUS$29.4b-US$197,911,000.0033.9x-1055.9x7.1x
Wed, 25 Jun 2025US$200.8bUS$29.4bUS$68.9m36.4x2914.1x6.8x
Fri, 23 May 2025US$194.0bUS$29.7bUS$181.8m31.2x1066.8x6.5x
Sun, 20 Apr 2025US$197.3bUS$28.7b-US$1,068,162,000.0034.3x-184.7x6.9x
Tue, 18 Mar 2025US$201.1bUS$28.7b-US$1,068,162,000.0035.5x-188.3x7x
Thu, 13 Feb 2025US$187.8bUS$28.0b-US$1,570,646,000.0039.2x-119.6x6.7x
Sat, 11 Jan 2025US$176.1bUS$27.4b-US$1,625,663,000.0040.4x-108.3x6.4x
Mon, 09 Dec 2024US$185.0bUS$27.4b-US$1,625,663,000.0043.9x-113.8x6.8x
Wed, 06 Nov 2024US$190.6bUS$27.0b-US$817,899,000.0048.3x-233x7.1x
Fri, 04 Oct 2024US$184.0bUS$26.2b-US$1,429,354,000.0054.5x-128.7x7x
Sun, 01 Sep 2024US$177.6bUS$26.2b-US$1,429,354,000.0052.5x-124.3x6.8x
Tue, 30 Jul 2024US$162.8bUS$26.3b-US$1,143,916,000.0048.9x-142.3x6.2x
Thu, 27 Jun 2024US$149.8bUS$26.1b-US$1,195,454,000.0043.2x-125.3x5.7x
Sat, 25 May 2024US$126.5bUS$23.1b-US$1,239,464,000.0037.6x-102.1x5.5x
Mon, 22 Apr 2024US$116.7bUS$22.6b-US$276,709,000.0041.9x-421.7x5.2x
Wed, 20 Mar 2024US$115.9bUS$22.5b-US$241,386,000.0040.8x-480x5.1x
Fri, 16 Feb 2024US$115.8bUS$23.3bUS$215.4m35.8x537.7x5x
Sun, 14 Jan 2024US$117.9bUS$22.9bUS$87.5m47.7x1347.5x5.1x
Tue, 12 Dec 2023US$113.6bUS$22.9bUS$87.5m43x1298.9x5x
Thu, 09 Nov 2023US$107.0bUS$22.9bUS$57.3m37.8x1868x4.7x
Sat, 07 Oct 2023US$103.0bUS$22.6bUS$502.0m30.7x205.1x4.6x
Mon, 04 Sep 2023US$110.1bUS$22.6bUS$511.5m33.7x215.2x4.9x
Wed, 02 Aug 2023US$116.2bUS$22.2bUS$735.1m34.1x158x5.2x
Fri, 30 Jun 2023US$109.0bUS$22.0bUS$785.0m32.7x138.8x5x
Sun, 28 May 2023US$100.8bUS$21.8bUS$840.1m29.4x120x4.6x
Price to Earnings Ratio

120x


Total Market Cap: US$100.8bTotal Earnings: US$840.1mTotal Revenue: US$21.8bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Health Care REITs Industry Price to Earnings3Y Average 345.9x202420252026
Current Industry PE
  • Investors are pessimistic on the American Health Care REITs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 178x which is lower than its 3-year average PE of 346x.
  • The 3-year average PS ratio of 6.4x is lower than the industry's current PS ratio of 8.3x.
Past Earnings Growth
  • The earnings for companies in the Health Care REITs industry have grown 24% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Real Estate industry?

US Market-0.32%
Real Estate0.50%
Health Care REITs-0.49%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
OHI Omega Healthcare InvestorsUS$48.992.1%
+US$294.8m		34.4%PB2.8x
NHI National Health InvestorsUS$77.483.3%
+US$120.7m		6.2%PB2.5x
ARE Alexandria Real Estate EquitiesUS$47.841.2%
+US$99.3m		-30.2%PB0.5x
NHP National Healthcare PropertiesUS$14.4910.1%
+US$97.8m		n/aPB1.8x
DHC Diversified Healthcare TrustUS$9.134.6%
+US$96.8m		190.8%PB1.4x

Latest News

CTRE
US$41.49
CareTrust REIT
7D
-2.2%
1Y
44.0%
DHC
US$9.13
Diversified Healthcare Trust
7D
4.6%
1Y
190.8%
NHP
US$14.49
National Healthcare Properties
7D
10.1%
1Y
n/a
New Narrative • May 20

Aging Demographics And Senior Housing Focus Will Support This Healthcare REIT’s Long Term Outlook

Catalysts About National Healthcare Properties National Healthcare Properties is a publicly traded health care REIT focused primarily on senior housing communities in the United States. What are the underlying business or industry changes driving this perspective?
HR
US$20.47
Healthcare Realty Trust
7D
0.5%
1Y
42.5%
Seeking Alpha • May 19

Healthcare Realty Trust: Betting On Outpatient Demand Growth, Lower Operator Risk (Upgrade)

Summary Healthcare Realty Trust is well positioned in the outpatient medical REIT space, benefiting from macro trends like aging demographics and rising outpatient care demand. HR's growth is supported by a nationwide portfolio, strong tenant retention, and opportunities for property acquisitions and lease growth. Balance sheet risk is mitigated by competitive debt metrics and diversified asset exposure. Valuation remains attractive relative to peers, with technical patterns and forward P/FFO supporting a favorable risk/reward profile for income-focused investors. The dividend story is where this stock shows a lack of a compelling growth trend, along with thin AFFO coverage. Read the full article on Seeking Alpha
NHI
US$77.48
National Health Investors
7D
3.3%
1Y
6.2%
OHI
US$48.99
Omega Healthcare Investors
7D
2.1%
1Y
34.4%
Narrative Update • May 17

OHI: Senior Housing Expansion And External Deals Will Guide Balanced 2026 Outlook

Narrative Update on Omega Healthcare Investors The analyst price target for Omega Healthcare Investors has been revised higher by $0.75 to $50.13. This reflects a series of recent target increases from multiple firms as analysts highlight updated sector views and company specific factors.
SBRA
US$21.06
Sabra Health Care REIT
7D
-0.2%
1Y
21.9%
Seeking Alpha • May 17

Sabra Health Care REIT A Buy, As Q1 Results Show Portfolio Growth

Summary Sabra Health Care REIT is rated a buy, reflecting portfolio growth, reasonable valuation, and robust geographic diversification. SBRA demonstrates strong revenue and NOI growth but faces declining EBITDA margins and flat long-term dividend growth, tempering its income appeal. The REIT maintains an investment-grade balance sheet, modest debt-to-equity, low operator concentration, and adequate AFFO dividend coverage with a 5.6% yield. Technical momentum remains bullish, with an +8% upside forecast by 2027, though sector risks include rising labor costs and potential shifts toward home healthcare. Read the full article on Seeking Alpha
VTR
US$88.60
Ventas
7D
-1.9%
1Y
39.3%
ARE
US$47.84
Alexandria Real Estate Equities
7D
1.2%
1Y
-30.2%
Narrative Update • May 17

ARE: Governance Shift And Margin Outlook Will Support Future Upside Potential

Analysts have trimmed their price target for Alexandria Real Estate Equities by a little over $2 per share, citing updated assumptions that reflect a slightly higher discount rate, softer revenue expectations, and a modestly stronger profit margin outlook, which together feed into a recalibrated future P/E estimate. What's in the News On March 31, 2026, Alexandria Real Estate Equities filed Articles Supplementary in Maryland to opt out of Section 3-804(a) of the Maryland General Corporation Law, removing the statutory requirement for a two thirds stockholder vote to remove directors (Key Developments).
WELL
US$218.61
Welltower
7D
-0.7%
1Y
47.4%
XRN
US$36.25
Chiron Real Estate
7D
5.6%
1Y
15.6%
DOC
US$19.66
Healthpeak Properties
7D
0.6%
1Y
16.8%
Narrative Update • May 13

DOC: Buyback Activity And Raised Earnings Outlook Will Mask Weaker Margin Outlook

Analysts have kept their $16.00 price target on Healthpeak Properties unchanged, citing updated assumptions that include a slightly higher discount rate, a shift to declining revenue growth, lower profit margins, and a much higher future P/E estimate. What's in the News From January 1, 2026 to May 5, 2026, Healthpeak Properties repurchased 5,950,000 shares, representing 0.86% of its stock for US$100 million under its existing buyback program (Key Developments).
SILA
US$30.25
Sila Realty Trust
7D
-1.0%
1Y
21.2%
JAN
US$26.69
Janus Living
7D
-2.3%
1Y
n/a